These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 11341936)

  • 21. Phenylguanidines as selective nonpeptide melanocortin-5 receptor antagonists.
    Chen C; Yu J; Fleck BA; Hoare SR; Saunders J; Foster AC
    J Med Chem; 2004 Jul; 47(16):4083-8. PubMed ID: 15267247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteo-chemometrics analysis of MSH peptide binding to melanocortin receptors.
    Prusis P; Lundstedt T; Wikberg JE
    Protein Eng; 2002 Apr; 15(4):305-11. PubMed ID: 11983931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-operative regulation of ligand binding to melanocortin receptor subtypes: evidence for interacting binding sites.
    Kopanchuk S; Veiksina S; Petrovska R; Mutule I; Szardenings M; Rinken A; Wikberg JE
    Eur J Pharmacol; 2005 Apr; 512(2-3):85-95. PubMed ID: 15840392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long term orexigenic effect of a novel melanocortin 4 receptor selective antagonist.
    Skuladottir GV; Jonsson L; Skarphedinsson JO; Mutulis F; Muceniece R; Raine A; Mutule I; Helgason J; Prusis P; Wikberg JE; Schiöth HB
    Br J Pharmacol; 1999 Jan; 126(1):27-34. PubMed ID: 10051117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations in the carboxyl terminus of the agouti protein decrease agouti inhibition of ligand binding to the melanocortin receptors.
    Kiefer LL; Ittoop OR; Bunce K; Truesdale AT; Willard DH; Nichols JS; Blanchard SG; Mountjoy K; Chen WJ; Wilkison WO
    Biochemistry; 1997 Feb; 36(8):2084-90. PubMed ID: 9047307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Three-dimensional molecular models of the hMC1R melanocortin receptor: complexes with melanotropin peptide agonists.
    Haskell-Luevano C; Sawyer TK; Trumpp-Kallmeyer S; Bikker JA; Humblet C; Gantz I; Hruby VJ
    Drug Des Discov; 1996 Dec; 14(3):197-211. PubMed ID: 9017363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyrotropin releasing hormone (TRH) selectively binds and activates the melanocortin 1 receptor.
    Schiöth HB; Prusis P; Muceniece R; Mutulis F; Mutule I; Wikberg JE
    Peptides; 1999; 20(3):395-400. PubMed ID: 10447100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling of the three-dimensional structure of the human melanocortin 1 receptor, using an automated method and docking of a rigid cyclic melanocyte-stimulating hormone core peptide.
    Prusis P; Schiöth HB; Muceniece R; Herzyk P; Afshar M; Hubbard RE; Wikberg JE
    J Mol Graph Model; 1997 Oct; 15(5):307-17, 334. PubMed ID: 9640562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The MC3 receptor binding affinity of melanocortins correlates with the nitric oxide production inhibition in mice brain inflammation model.
    Muceniece R; Zvejniece L; Liepinsh E; Kirjanova O; Baumane L; Petrovska R; Mutulis F; Mutule I; Kalvinsh I; Wikberg JE; Dambrova M
    Peptides; 2006 Jun; 27(6):1443-50. PubMed ID: 16414147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melanocortin receptors: ligands and proteochemometrics modeling.
    Wikberg JE; Mutulis F; Mutule I; Veiksina S; Lapinsh M; Petrovska R; Prusis P
    Ann N Y Acad Sci; 2003 Jun; 994():21-6. PubMed ID: 12851294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of melanocortin peptides on neural melanocortin receptors.
    Adan RA; Cone RD; Burbach JP; Gispen WH
    Mol Pharmacol; 1994 Dec; 46(6):1182-90. PubMed ID: 7808440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteochemometric modeling reveals the interaction site for Trp9 modified alpha-MSH peptides in melanocortin receptors.
    Lapinsh M; Prusis P; Petrovska R; Uhlén S; Mutule I; Veiksina S; Wikberg JE
    Proteins; 2007 May; 67(3):653-60. PubMed ID: 17357163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R.
    Haskell-Luevano C; Hendrata S; North C; Sawyer TK; Hadley ME; Hruby VJ; Dickinson C; Gantz I
    J Med Chem; 1997 Jul; 40(14):2133-9. PubMed ID: 9216831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Agouti antagonism of melanocortin-4 receptor: greater effect with desacetyl-alpha-melanocyte-stimulating hormone (MSH) than with alpha-MSH.
    Mountjoy KG; Willard DH; Wilkison WO
    Endocrinology; 1999 May; 140(5):2167-72. PubMed ID: 10218968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glutamine235 and arginine272 in human melanocortin 5 receptor determines its low affinity to MSH.
    Frändberg PA; Xu X; Chhajlani V
    Biochem Biophys Res Commun; 1997 Jul; 236(2):489-92. PubMed ID: 9240466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
    Frändberg PA; Doufexis M; Kapas S; Chhajlani V
    Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Receptor biology of the melanocortins, a family of neuroimmunomodulatory peptides.
    Tatro JB
    Neuroimmunomodulation; 1996; 3(5):259-84. PubMed ID: 9218248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular determinants of melanocortin 4 receptor ligand binding and MC4/MC3 receptor selectivity.
    Nickolls SA; Cismowski MI; Wang X; Wolff M; Conlon PJ; Maki RA
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1217-27. PubMed ID: 12604699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deletions of the N-terminal regions of the human melanocortin receptors.
    Schiöth HB; Petersson S; Muceniece R; Szardenings M; Wikberg JE
    FEBS Lett; 1997 Jun; 410(2-3):223-8. PubMed ID: 9237634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.